J Crohns Colitis
-
Publication Venue For
- Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.. 15:1362-1375. 2021
- Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.. 15:1184-1196. 2021
- Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.. 15:733-741. 2021
- Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.. 13:693-701. 2019
- Long-term efficacy and safety of azathioprine in ulcerative colitis.. 9:191-197. 2015
- Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease.. 8:375-383. 2014
- Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.. 7:853-867. 2013
- Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.. 6:143-153. 2012
- Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.. 5:324-331. 2011